Babu Yarlagadda S
SEC CIK 1452635 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BCRX | BIOCRYST PHARMACEUTICALS INC | Chief Discovery Off | 330.1K | — | $1.15M | 6 | 2021-12-07 | 2022-11-14 |
Most active insiders at BCRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Barnes Alane P | CLO | — | $3.46M |
| 2 | HEGGIE THERESA | Dir | — | $504.8K |
| 3 | McKee Amy E | Dir | — | $100.3K |
| 4 | SANDERS MACHELLE | Dir | — | $68.5K |
| 5 | Menon Sandeep | Chief R, D Off | — | — |
| 6 | Ghias Babar | CFO | — | — |
| 7 | Gayer Charles K | Pres, CCO | — | — |
| 8 | Milne Jill C. | Dir | — | — |
| 9 | Frank Steven | Dir | — | — |
| 10 | Galson Steven K | Dir | — | — |
Babu Yarlagadda S made no open-market trades at BCRX in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-11-16 | 2022-11-14 | BCRX | BIOCRYST PHARMACEUTICALS INC | Babu Yarlagadda S | Chief Discovery Off | M - OptEx | $1.42 | +100.0K | 330.1K | +43% | +$142.0K |
| D | 2022-11-16 | 2022-11-14 | BCRX | BIOCRYST PHARMACEUTICALS INC | Babu Yarlagadda S | Chief Discovery Off | S - Sale+OE | $13.88 | -31.5K | 298.5K | -10% | -$437.4K |
| 2022-03-09 | 2022-03-07 | BCRX | BIOCRYST PHARMACEUTICALS INC | Babu Yarlagadda S | Chief Discovery Off | S - Sale | $17.16 | -20.0K | 230.1K | -8% | -$343.2K | |
| D | 2021-12-16 | 2021-12-14 | BCRX | BIOCRYST PHARMACEUTICALS INC | Babu Yarlagadda S | Chief Discovery Off | A - Grant | $0.00 | +35.0K | 250.1K | +16% | $0 |
| D | 2021-12-09 | 2021-12-07 | BCRX | BIOCRYST PHARMACEUTICALS INC | Babu Yarlagadda S | Chief Discovery Off | S - Sale+OE | $12.20 | -30.1K | 215.1K | -12% | -$367.2K |
| D | 2021-12-09 | 2021-12-07 | BCRX | BIOCRYST PHARMACEUTICALS INC | Babu Yarlagadda S | Chief Discovery Off | M - OptEx | $4.73 | +62.0K | 245.2K | +34% | +$293.3K |
Purchase Sale Sale after option exercise All abbreviations